Evidence mapPaperPMID 36799408Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2023

Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network.

Sarinnapha M Vasunilashorn, Nadia Lunardi, John C Newman, Gregory Crosby, Leah Acker, Ted Abel, Seema Bhatnagar, Colm Cunningham, Rafael de Cabo, Laura Dugan and 9 more

Open access · hybridAbstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. The ICU environment paradigm as a catalyst for better delirium models.Clinical science (London, England : 1979) · 2026
    Article
  4. Article
  5. Animal models of delirium: a narrative review.Translational psychiatry · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Catalyzing delirium research: The NIDUS delirium network.Journal of the American Geriatrics Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 3 countries.

Sarinnapha M VasunilashornDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Nadia LunardiDepartment of Anesthesiology, University of Virginia, Charlottesville, Virginia, USA.
John C NewmanDepartment of Medicine, University of California, San Francisco, California, USA.
Gregory CrosbyHarvard Medical School, Boston, Massachusetts, USA.
Leah AckerDepartment of Anesthesiology, Duke University, Durham, Massachusetts, USA.
Ted AbelDepartment of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Seema BhatnagarDepartment of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Colm CunninghamSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland.
Rafael de CaboTranslational Gerontology Branch, Intramural Research Program, National Institute on Aging, Baltimore, Maryland, USA.
Laura DuganVanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee, USA.
Joseph A HippensteelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Yumiko IshizawaHarvard Medical School, Boston, Massachusetts, USA.
Shouri LahiriDepartment of Neurology, Neurosurgery, and Biomedical Sciences, Cedar-Sinai Medical Center, Los Angeles, California, USA.
Edward R MarcantonioDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Zhongcong XieHarvard Medical School, Boston, Massachusetts, USA.
Sharon K InouyeHarvard Medical School, Boston, Massachusetts, USA.
Niccolò TerrandoDepartment of Anesthesiology, Duke University, Durham, North Carolina, USA.ORCID 0000-0003-1803-5853
Roderic G EckenhoffDepartment of Anesthesiology and Critical Care, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
NIDUS Delirium Network
Beth Israel Deaconess Medical Center · USDuke University · USHarvard University · USBrigham and Women's Hospital · USBuck Institute for Research on Aging · USCedars-Sinai Medical Center · USChildren's Hospital of Philadelphia · USNational Institute on Aging · USTrinity College · CAUniversity of Colorado Anschutz Medical Campus · USUniversity of Iowa · USUniversity of Pennsylvania · USUniversity of Virginia · USVanderbilt University · US

Funding

Microglia-Amyloid interactions in delirium superimposed on dementiaR01AG057525 · NIA · DUKE UNIVERSITY · 2024 to 2025
$1.7M
Brain Vulnerability in Delirium and Alzheimer’s Disease and Related Dementias: Intersection of Polygenic Risk and InflammationR01AG079864 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · 2023 to 2025
$1.7M
NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in DeliriumR33AG071744 · NIA · HEBREW REHABILITATION CENTER FOR AGED · 2023 to 2025
$1.6M
Immunovascular interactions in postoperative delirium superimposed on dementia (DSD).RF1AG079138 · DUKE UNIVERSITY · 2025 to 2025
$1.4M
Lung-Brain Axis as a Mediator of DeliriumK08HL159353 · UNIVERSITY OF COLORADO DENVER · 2025 to 2025
$162k
NHLBI NIH HHS K08 HL159353NHLBI NIH HHS K08HL159353NIA NIH HHS K01 AG057836NIA NIH HHS K01AG057836NIA NIH HHS R01 AG051812NIA NIH HHS R01 AG057525NIA NIH HHS R01 AG058856NIA NIH HHS R01 AG068025NIA NIH HHS R01 AG079864NIA NIH HHS R03 AG061582NIA NIH HHS R03 AG074056NIA NIH HHS R33 AG071744NIA NIH HHS RF1 AG079138
6 · The paper itself

Abstract

Delirium is a common, morbid, and costly syndrome that is closely linked to Alzheimer's disease (AD) and AD-related dementias (ADRD) as a risk factor and outcome. Human studies of delirium have advanced our knowledge of delirium incidence and prevalence, risk factors, biomarkers, outcomes, prevention, and management. However, understanding of delirium neurobiology remains limited. Preclinical and translational models for delirium, while challenging to develop, could advance our knowledge of delirium neurobiology and inform the development of new prevention and treatment approaches. We discuss the use of preclinical and translational animal models in delirium, focusing on (1) a review of current animal models, (2) challenges and strategies for replicating elements of human delirium in animals, and (3) the utility of biofluid, neurophysiology, and neuroimaging translational markers in animals. We conclude with recommendations for the development and validation of preclinical and translational models for delirium, with the goal of advancing awareness in this important field.

Indexed as

Alzheimer DiseaseDeliriumAnimalsHumansIncidenceNeuroimagingRisk Factorsanimal modelsbiomarkersdelirium

Identifiers

PMID36799408
PMCPMC10576242
OpenAlexW4321172615

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.